Sidra Selects WuXi NextCODE to Power Population Genomics and Precision Medicine in Qatar

We are excited to share with you that our wholly owned subsidiary, WuXi NextCODE, has partnered with Sidra Medical and Research Center (Sidra), a groundbreaking hospital, research and education institution, to provide...

WuXi Corporate Venture Fund Invests in Innovative Cancer Imaging Business

We are delighted to share with you that  WuXi Corporate Venture Fund has contributed to a $6.85 million Series B round financing of Avelas Biosciences, Inc., a San Diego-based biotech that is developing an...

WuXi Genome Center Purchases an Illumina HiSeq X Ten Sequencing System

WuXi is pleased to announce that we have purchased an Illumina HiSeq X Ten sequencing system for the WuXi Genome Center.  This new investment will enhance WuXi’s clinical genomic services from...

WuXi Acquires Crelux

We are thrilled to announce that we have acquired Crelux GmbH, a leading structure based drug discovery provider based in Munich, Germany. The addition of Crelux enhances WuXi’s structure-based drug discovery capabilities and establishes...

deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide

Congratulations to the scientists at deCODE genetics on their publication of the largest-ever set of human genomes from a single population and the consequent insights into mutation, evolution, gene function and...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Artificial Intelligence Poised to Transform the Drug Industry from Laboratory to...

Artificial intelligence (AI) –  which learns from computer algorithms how to unravel complex genomic data, such as gene expression patterns of disease – is...